TNFRSF4 and cancer: Interestingly, CD252 (OX40L), the ligand of OX40, a T cell activation marker, was expressed on cancer cells of the PW(+) and MA groups similar to the PW(−) group (p < 0.05, p < 0.001, p < 0.05, respectively).